Amgen AMGN
NASDAQ AMGN
$437.23 -6.89 (-1.55%)
At close: Sep 4, 2026 · 4:00 PM EDT

Amgen (AMGN) EV to EBIT (2009 - 2026)

Amgen (AMGN) posted EV to EBIT of 51.73 for Q2 2026, down 22.46% on a QoQ basis from 66.71 in Q1 2026, and down 3.43% year-over-year from 53.57 in Q2 2025.

Analysis

Amgen (AMGN) EV to EBIT (2009 - 2026) Analysis & Trends

Amgen has reported EV to EBIT for 18 years, with the latest figure at 51.73 in Q2 2026.

  • On a quarterly basis, EV to EBIT fell 3.43% year-over-year to 51.73 in Q2 2026; TTM through Jun 2026 was 15.91, a 8.4% decrease from a year earlier, with the FY2025 full-year figure at 18.42, up 4.46% from the prior year.
  • EV to EBIT was 51.73 for Q2 2026 at Amgen, down from 66.71 in the prior quarter.
  • The five-year high for EV to EBIT was 144.1 in Q1 2024, with the low at 31.49 in Q2 2023.
  • Average EV to EBIT over 5 years is 68.97, with a median of 56.46 recorded in 2022.
  • The sharpest annual moves came in 2022 and 2024: EV to EBIT slumped 64.22% in 2022, then surged 183.72% in 2024.
  • Over 5 years, EV to EBIT stood at 58.72 in 2022, then jumped by 91.96% to 112.72 in 2023, then plunged by 50.87% to 55.37 in 2024, then climbed by 11.03% to 61.48 in 2025, then fell by 15.86% to 51.73 in 2026.
  • The last three EV to EBIT figures came in at 51.73 (Q2 2026), 66.71 (Q1 2026), and 61.48 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.73
Mar 31, 2026 66.71
Dec 31, 2025 61.48
Sep 30, 2025 56.42
Jun 30, 2025 53.57
Mar 31, 2025 134.73
Dec 31, 2024 55.37
Sep 30, 2024 80.20
Jun 30, 2024 83.05
Mar 31, 2024 144.10
Dec 31, 2023 112.72
Sep 30, 2023 53.97
Jun 30, 2023 31.49
Mar 31, 2023 50.79
Dec 31, 2022 58.72
Sep 30, 2022 40.89
Jun 30, 2022 56.51
Mar 31, 2022 49.05
Dec 31, 2021 51.03
Sep 30, 2021 45.09